HARRY Fl CH M.D.
HARRY Fl CH M.D.
tel:
fax:
FACSIMILE TRANSMISSION
Date: Y\qIIL
r5 re i Ai PLEASE DELIVER ATTACHED MESSAGE
TO: Ze__-_Q-c,g,ei
FAX #: TEL #:
Regarding:
Number of pages (including cover
Remarks: page):
Vt9L896Z121. LPsti L ieH LSdL£' L abed
EFTA00582641
115.0 allev ',VT. bwri label Na RAW <AN raftl•st••••••••• • • •••• rwrxr • h. v j •
I ..r.•• Ft PA army, e. A . wariot*
lMaimis 3,•24 tam:ha. Bea Liked med
te.to d fie bzr Anorat .r.A.M.O. :ary •
miler gfir ;WAX Do., '
EFTA00582642
M9 09 2016 0a37RI Harry Fitt' 12129881630 page 3
Qyavv?-7yryy
ki-vvn ineyb
vs>f
EFTA00582643
BioReference
<EPSTEIN,
1M08:01/23/1953
Address:3
' NEW YOR‹.
P:
2
ott at
'r$ `.r FINAL REPORT
r ---,..,,,r
LABORATORIES
0 Mai, HARRY
.. 0 FARRY FISCH, M.O.
544 PARK AVENUE C hew Ye-kJ NY 10028
Acct 4' C1720-1) Si
0 P:
R lErrREY
Age:63 V Sex:M
E 71ST ST'CET
NV 10021 5 Specimen ID: 105819158
A Date Of Report: 07/23/2016
m Date Collected: 07/2012016
Time Collected: 08:52
PDate Received: 07/20/2016
L Time Received: 23:20
E
No-th America Eastern Tine
C_INIIC,AL RE-)OR—
Clinical Abnormalities Summary: Maynci3OlawallebnortremSullSmeaffirta.AsmiynNaMe$08M41188flabUenewelnempon)
Creatinine 0.6210 EON/Great Ratio
Cholesterol 210 HI Triglycerides
HDL as % of 13 Chol/HDL Kati)
Cholesterol
MCHC 35.2 HI
Hemoglobin Alc 5.9 HI 33.9 HI ALT 42 NI
950 NI HDL CHOL., DIRECT 28 LO
7.5
NON FASTINS
'<"? .171.. ' - e ,. l'I'ql.'t ,t
Total Protein 7.0 5.9-H.4 g/d1 6.7 01/27/2016
Albumin 4.7 3 5 5.2 g/dL 4.2 01/27/2016
Globulin 2.3 1.7-3.7 g/dL 2.5 01/27/2016
A/G Ratio 2.0 1.1-2.9 1.7 01/27/2016
Glucose 93 78-99 mg/dL 99 01/27/2016
Sodium 140 135-147 mtol/L 141 01/27/2016
Potassium 4.6 3.5-5.5 meol/L 4.2 01/27/2016
Chloride 97 96-108 meol/L 102 01/27/2016
CO2 24 22-29 miol/L 26 01/27/2016
BUN 21 8-23 mg/di. 22 01/27/2016
Creatinine 0.62 tO 0.80-1.30 mg/dL 1.11 01/27/2816
e-GFR 106 >or 60 mL/min 70 01/27/2016
e-GFR, African American 123 >or-60 mL/min 81 01/27/2016
OUN/Creat Ratio 33.9 HI 10.0-28.0 19.8 01/27/2816
Calcium 9.8 8.6.10.4 mg/dL 9.8 01/27/1016
Uric Acid 7.4 3.4-8.5 mg/dL 7.5 01/27/2016
Iron 96 45-160 ug/dL 75 01/27/2016
8111rubin, Total 0.6 <1.2 mg/dL 0.5 81/27/2818
LD 206 135-225 U/L 171 01/27/2016
Alk Phos 79 40-156 U/L 43 01/27/2016
13T 32 <40 U/L 29 01/27/2016
Phosphorus 3.8 2.7.4.5 mg/dL 3.4 01/27/2016
ALT 42 HI <41 U/L 29 81/27/2816
GGTP 19 10-71 U/L 18 01/27/2016
Cholestero 210 Al <200 •L 143 li-
01/27/2016
Triglycerides 950 HI
NOTE: The result for Triglycerides has been confirmed <150 mg/dL
by repeat analysis. 459 HI 01/27/2016
NEIL COL., DIRECT 28 LO >40 mg/dL 24 LO 01/27/2016
HDL as % of Cholesterol 13
Evaluation: ABOVE AV6.(MODERATE RISK) >14 X 17 01/27/2016
Chol/HDL Ratio 7.5 <7.4 6.0 01/27/2016
BioReference Laboratories, Inc.
481 Edward H. Ross Dr Elmwood Park, N7 07407 I (800) 2 9-5227 lames 4eisberger,
Laboratory Director Clinical Page 1 of 6
Printed 07/25/2016 07:01
p gad b£91.886ZLZ1. ipsu LueH itILE:CO 91.12 60 6nV
EFTA00582644
BioReference
I. ABORATORIES
• Of.--EPSTEIN,
.1",.:It:D06:01/20/1953
% ,IAddress:) i,
.NEW YORK,YORK,
•,' 'IeitFINAL IC t PUN I
D
. 0
CT
0
R FISCH, HARRY
HARRY EISCF, M.D.
q44 PARK AVCNU:
fie4 York NY 10028
Acct t: C1720-1) 51
). JEFFREY Specimen ID: 105819158
Age:63 V Sex:M Date Of Report: 07/23/2016
E 71ST STREET Date Collected: 07/20/2016
NY 10221 Time Collected: 08:52
Date Received: 07/20/2016
Time Received: 23:70
north America Eastern Time i
CLINICAL REPORT
(F.P.A—r: _
Evaluation: ABOVE AVG.(MOCIERATE RISK) ..:& `7.43-frAtroWIteci; ,:-. ... i Itoi;e
LDL/HOL Ratio Can't Calc <3.56 Can't Calc 01/27/2016
LOL Cholesterol Can't Calc
NOTE: Unable to calculate LOL due to a Triglyceride 'evel <100 mg/di Can't Calc
of greater than 400 mg/d1. 01/27/2016
VLDL, CALCULATED Can't Celt 7-32 mg/dL I Can't talc 01/27/2016
Can't Calc: One or more components was outside the measurable
range. We are unable to calculate.
I ICL i ;',
7.79 3.66-11.99 x10 3 /LA 7.12 01/27/2016
R8C 5.18 4.20-5.90 x10(6)/uL 4.96 01/27/2016
HUT 15.4 22.3-17.0 ge/di. 14.3 01/27/2016
HCT 43.8 39.3-52.5 % 41.3 01/27/2016
MCV 84.6 80.0-100.0 fL 83.3 01/27/2016
NCH 29.7 25.0-34.1 pg 28.8 01/27/2016
MCHC 35.2 HI 29.0-35.0 ge/dL 34.6 01/27/2016
ROW 14.8 10.9-16.9 % 13.9 01/27/2016
POLYS 45.8 36.0-78.0 % 49.2 01/27/2016
LYMPHS 39.0 12.0-48.0 % 36.2 01/27/2016
MONOS 6.9 0.0-13.0 % 7.6 01/27/2016
EOS 5.4 0.0-8.0 % 6.5 01/27/2016
BASOS 0.6 0.0-2.0 % 0.4 01/27/2016
IMMATURE GRANULOCYTES 0.0 0.0.1.6 % 0.1 01/27/2016
PLATELET COUNT 281 144-400 x10(3)/UL 222 01/27/2016
MPV 8.9
NOTE: New reference ranges for WIC and Absolute coun:s 8.2-11.9 fL
are effective 4/25/2016. 9.5 01/27/2016
PT TNP
Test Not Performed: Specimen REJECTED for testing du! 9.1-11.9 sec 10.1 01/27/2016
to GROSS LIPEMIA.
INTR.KORN.RATIO(INR) TNP 2.08-3.00 0.97 LO 01/27/2016
PTT TNP
I P.IN,H.S1-IS
.S.1_ ....., .' .. _.,, „.,4gaiebit.=5) tagglitCum... -;.:‘,4•C;
Co or YELLOW 23.6-31.6 sec
;4.;26.5
"-<"":—.""i7" 01/27/2016
en Ci.• ,
YELLOW,
STRAW, AMBER
Character CLEAR CLEAR
Specific Gravity Ur 1.025 1.003 -
1.030
pH urine 6.5 5.0 - 8.0
Protein, Urine NEGATIVE NEGATIVE
Glucose, Urine NEGATIVE NEGATIVE
Ketone, Urine NEGATIVE NEGATIVE
Urobilinogen Urine 0.2 0.2 - 1.0 eg/dL
BioReference Laboratories, Inc.
481 Edward H. Rcss Dr I Elredood Park, m1 07407 I (Bee) 2 lames Weisberger, ill. Clinical Page 2 of 6
-5227 Laboratory Director Printed 07/25/2016 07:01
g abed VE9L886Z2L ipsu GBH 14:18E:50 9102 60 find
EFTA00582645
BioReferenceFINAL
LABORATORIES
a.;:;,,:.
,FAIqk EPSTEIN,
)1000:01/28/1953
':: • '' Address:]
NEW YORK
P:
;,.gg
:•
.i„'"cREPORT
D
0
C
0
R FISCH, HARRY
HARRY FISCH, H.D.
944 PARK AVENuL
Neo York, NY 10028
Acct e: C1720-1) SI
P: %
../ JEFFREY Specimen ID: 1050191S:I
Age:63 Y Sex:M Date Of Report:07/23/2016
E 71ST STREET Date Collected: 07/20/2016
NY 1x021 Time Collected: 08:52
Date Received: 07/20/2016
Time Received: 23:20
North America Eastern Time.."
CLINICAL REPORT
."- . ,t,,; sfa :41R,
Bilirubin, Urine NEGATIVE NEGATIVE
Blood, Urine NEGATIVE NEGATIVE
Nitrites Urine NEGATIVE NEGATIVE
Leukocyte Esterase NEGATIVE NEGATIVE
Crystals Urine NONE NONE
Crystal Mt. Urine NONE NONE
WIC, Urine 0-4 0-4 PER HPF
R2C, Urine NONE SEEN NONE SEEN PER HPF
Epithelial Cells, Ur NONE FEW
Cast, Hyaline, Urine 0-4 0-4 PER LPF
Cast, Granular, Ur NONE SEEN 0-1 PER LPF
Cast, RBC, Urine NONE SEEN 0-1 PER LPF
Bacteria, Urine NONE FEW
.I "( OGY
i ..... ...
CULTURE,
SITE:
M1SCILLANLOUS
ri:71:4:0:i:(41414fiditrei*.=4.-kar
Hemoglobin
HEMOGLOBIN
NOTE: URINE NO GROWTH
URINE
‘"
Alc 5.9 HI
A1c AND eAG REFERENCE RANGES
A1c(%) DIABETES CATEGORY*
<5.7 Normal (nom
5.7-6.4 Increased
.>6.5 Consistent
AIC(X) eAG(ESTIMATED AVERAGE
6 126
7 154
8 183
9 212
10 240
11 269
12 298
*recommended ranges -American Diabetes
Hemolysis, rare hemoglobin variants and thalassemia NO GROWTH
W.r.4,11:::::=ViiiiirLaarigaTZ2=C7.31, illiat,W4 24:
<5.7 6.0 HI lin/27/2016
-diabetic)
risk of diabetes
with diabetes
PLASMA GLUCOSE)(mg/dL)
Association(2010)
major may affect glycemic results.
TSH TNP
Test Not Performed: Specimen rejected for testing due
hemolysis. 0.178-4.530 uIU/s0. I 1.790 101/27/2016
to moderate or marked
Thyroxine(T4) TNP
Test Not Performed: Specimen rejected for testing duo 4.9.12.9 ug/dE I 6.3 181/27/2016
to moderate or marked
BloRefe-ence Laboratories, Inc. Tares Weisoerger, III. Clinical Page 3 of 6
481 Edward H. Ross Dr I Eltmood Park, N7 07407 I (800) 2 -5227 Laboratory Director Printed 07/25/2016 07:01
g abed 17£91286Z121, I-PsH fLueH 14:16E:SO 9102 60 6ny
EFTA00582646
tt f ...,ence LABORATORIES FINAL REPORT
0, FISCH, HARRY \
0 HARRY FISCH, M.D.
( 944 PARK AVENUE
New York, NY 10028
Acct P: (C1720-1) Si
C P:
R EPSTEIN,
D08:01/20/1953
Address:9
s 'OM YORK
IP: gliNS JEFFREY Specimen ID: 105819158
Age:63 Y Sex:Pt Date Of Report: 07/23/2016
E 71ST STREET Date Collected: 87/20/2016
NY 10021 Time Collected: 08:52
Date Received: 07/20/2816
Time Received: 23:20
North America Eastern Time ,/
CLINICAL REPORT
hemolysis. .
T3 Uptake(T3U) TNP
Test Not Performed: Specimen rejected for testing due
hemolysis. 24.3.39.0 %
to moderate or marked 29.3 101/27/2016
THYROXINE, FREE(FT4) TNP
lest Not Performed: Specimen rejected for testing due
hemolysis. 0.80-1.73 ng/dL
to moderate or marked 0.93 101/27/2016
FREE T4 INDEX TNP 1.5-3.8 1.8 01/27/2016
113(THYRONINE), TOTAL TNP
Test Not Performed: Specimen rejected for testing due
hemolysis. 72-180 ng/dL
to moderate or narked 127 01/27/2016
PSA Total TNP
Test Not Performed: Specimen rejected for testing due
hemolysis.
NOTE: The PSA assay should not be the only test used
Additional evaluation using DRE, ultrasound, T
be used for this purpose. Predictions of disease
based solely upon values obtained from serial PSA
Patient.
NOTE: Values obtained with different assay methods or
used interchangeably.
NOTE: Results cannot be interpreted as absolute evidence
absence of malignant disease.
ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay <4.00 ng/mL
to moderate or marked
for diagnostic purposes.
R or similar procedures may
recurrence should not be
values obtained on the
kits cannot be
of the presence or
(Roche Diagnostics) 0.70 101/27/2816
PSA, FREE TNP
Test Not Performed: Specimen rejected for testing du►
hemolysis.
NOTE: Results cannot be interpreted as absolute evidence
presence or absence of malignant disease. Values
with different assay methods or kits cannot be
interchangeably.
ASSAY INFORMATION: Method Electrocheedluninescence Immunoassay
(Roche Diagnostics). Not Estab. ng/mi.
to moderate or marked
of the
obtained
used 1 0.33 101/27/2016
% FREE PSA TNP
FREE PSA RISK ASSESSMENT
The probability of prostate cancer for men with non
age group, using PSA values between 4.000 and 10.00e
values is summarized in the table below: See Below %
-suspicious DRE results, by
ng/mt and percent FREE PSA I 47 101/27/2016
IlioReference Laboratories, Inc.
481 Edward H. Ross Dr I Elmwood Park, N3 07407 I (880) 2 James weisberger, M.D. Clinical Page 4 of 6
9-5227 Laboratory Director Printed 07/25/2016 07:01
L B6ed P€91.886ZLZI. iPsid H 14:104:SO 91O2 6O End
EFTA00582647
BioReference
LABORATORIES FINAL REPORT
D FISCH, HARRY
A HARRY FISCH, H.D.
L 944 PARK AVENUE
York, NY 10028 T
Acct a: C1720-1) S1
R EPSTEIN,
D00:01/20:1953
Address:,
NEW YORK
P: (212) JEFFREY
Age:63 Y Sex:m
E 71ST STREET
NY 10021
772-9c16
, ,s STRAKFTC4.4,0* iifkiiSii
(>or=70 yrs)
64.5%
40.8%
29.7%
15.8%
biopsy
ible when the value for
are for assays
em.(0/2015;V8.0) s Specimen ID: 105819158
A Date Of Report: 07/23/2016
v Date Collected: 07/20/2016
Time Collected: 08:52 P Date Received: 87/20/2016
Time Received: 23:20 I
North America Eastern Time
CLIN:CAL REPORT
• PROBABILITY OF CANCER*
%free PSA (50.59 yrs) (60-69 yrs)
corral:3 49.2% 57.5%
11-18 26.9% 33.9%
29-25 18.3% 23.9%
>25 9.1% 12.2%
'probability of finding prostate cancer by need :e
NOTE: Calculation of percent FREE PSA may not be post
TOTAL PSA is in the low normal range. These guidelines
performed using the Roche E602 immunoassay sys
TESTOSTERONE, TOT.,S. TOP
Test Not Pe-formed: Specimen rejected for testing due
hemolysis. 193.0.740.0 ng/dL
to moderate or marked 296.0 101/27/2016
TESTOSTERONE, 8/0AVAIL. TOP 72.0-460.0 ng/dL 183.8 01/27/2016
SEX HORM.BIND.GLOB. TOP
Test Not Performed: Specimen rejected for testing du
hemolysis. 18-57 nmol/L
to moderate or narked I
18 01/27/2016
FREE TESTOSTERONE TOP 30.00.150.00 pg/mL 80.18 01/27/2016
LH TOP
Test Not Performed: Specimen rejected for testing due
hemolysis. 1.7.8.6 mIU/Int
to moderate or marked I
6.8 01/27/2016
FSH TOP
Test Not Performed: Specimen rejected for testing due
hemolysis. 1.5-12.4 mIU/ral. 1
to moderate or marked 6.8 101/27/2016
PROLACTIN, SERUM TIP
Test Not Performed: Specimen rejected for testing due
hemolysis. 4.0-15.2 ng/ml.
to moderate or marked 3.0 LO 101/27/2016
ESTRADIOL TNP
Test Not Performed: Specimen rejected for testing due
hemolysis. 7.02-49.06 pg/mI
to moderate or marked 48.91 101/27/2016
FIBRINOGEN TNP 176-441 i/dL 276 01/27/2016
DIHYDROTESTOSTERIONE(7) 148.0
Reference Intervals for Males age 20 years and above:
106.0-719.0 pp/mL
Analysis by High Performance Liquid Chromatography/
Tandem:lass Spectrometry (LC-MS/I45) 106-719 pg/st 278.0 01/27/2016
(7)
Performed by: National Medical Lab
2300 Stratford Ave.
Willow Grove, PA 19090
BioReference Laboratories, Inc.
481 Edward H. Ross Dr I Elmwood Park, NJ 07407 I (800) lames weisberger, M.D. Clinical Page S of 6
-5227 Laboratory Director Printed 07/25/2016 07:01
8 abed 61918862 I.2 1-Psij AlmH kUOV40 9102 60 End
EFTA00582648
📷 Images in this document (8 detected; 6 largest described)
AI-generated factual descriptions of embedded images (llava:13b). These are searchable across the corpus.
[Image 1] The image shows a handwritten note on a lined paper. The note contains various scribbles and doodles, with some words and phrases that are legible, such as "help," "thank you," and "sorry." There are also some drawings and symbols, including a circle and a heart shape. The note appears to be a personal communication, possibly expressing gratitude or apologies. The paper has a watermark that reads
[Image 2] The image shows a document that appears to be a financial report or statement. It contains various tables and figures with numerical data, likely representing financial transactions or account balances. The document is titled "FINAL REPORT" and includes sections such as "SUMMARY," "DETAIL," and "BALANCE SHEET." There are also sections for "INCOME STATEMENT," "CASH FLOW STATEMENT," and "NOTES TO TH
[Image 3] The image shows a document that appears to be a clinical laboratory test report. It contains various columns with numerical values, which are likely to represent test results. The document is titled "Final Report" and includes sections for patient information, test details, and test results. There are also sections for comments and a signature, which are typically found in such reports. The visibl
[Image 4] The image shows a document that appears to be a financial report or statement. It includes sections for "Final Report," "Summary," and "Detail." There are tables with numerical data, likely representing financial figures such as income, expenses, and totals. The document is structured with headings and subheadings, and there are columns with numbers and descriptions. The text is too small to read
[Image 5] The image is a scanned document, specifically a clinical report or medical record. It contains various sections with headings such as "Patient Information," "Chief Complaint," "History of Present Illness," "Past Medical History," "Social History," "Family History," "Physical Examination," "Laboratory Data," and "Imaging Studies." There are also sections for "Assessment and Plan," "Differential Dia
[Image 6] The image shows a document that appears to be a financial report or statement. It contains various columns with numerical data, such as "Amount," "Date," and "Description." There are also sections for "Total," "Balance," and "Ending Balance." The document is structured with headings and subheadings, and it includes a footer with a disclaimer or notice. The text is too small to read in detail, but